GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (FRA:7C8) » Definitions » Days Sales Outstanding

Invion (FRA:7C8) Days Sales Outstanding : 0.00 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Invion Days Sales Outstanding?

Invion's average Accounts Receivable for the six months ended in Dec. 2024 was €0.00 Mil. Invion's Revenue for the six months ended in Dec. 2024 was €0.00 Mil.

The historical rank and industry rank for Invion's Days Sales Outstanding or its related term are showing as below:

FRA:7C8' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.73   Med: 17.35   Max: 505.05
Current: 505.05

During the past 13 years, Invion's highest Days Sales Outstanding was 505.05. The lowest was 2.73. And the median was 17.35.

FRA:7C8's Days Sales Outstanding is ranked worse than
98.33% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.25 vs FRA:7C8: 505.05

Invion's Days Sales Outstanding declined from Dec. 2023 (166.69) to Dec. 2024 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Invion Days Sales Outstanding Historical Data

The historical data trend for Invion's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invion Days Sales Outstanding Chart

Invion Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.47 19.50 8.34 77.87 158.88

Invion Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.52 82.24 166.69 304.23 -

Competitive Comparison of Invion's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Invion's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invion's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invion's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Invion's Days Sales Outstanding falls into.


;
;

Invion Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Invion's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

Days Sales Outstanding (A: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (0.992 + 0) / 1 ) / 2.279*365
=0.992 / 2.279*365
=158.88

Invion's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 2
=0 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invion  (FRA:7C8) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Invion Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Invion's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Invion Business Description

Traded in Other Exchanges
Address
692 High Street, East Kew, VIC, AUS, 3102
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.

Invion Headlines

No Headlines